Trial Details

COMPLETED
Basic Information
Clinical ID c2052
Identifier NCT04045782
Trial Title Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: single arm
Participant Information
Sponsor Pieter Dewint, MD PhD
City Oost-Vlaanderen
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2019-08-19
Primary Completion Date 2021-01-29
Completion Date 2021-01-29